![Keting Chu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Keting Chu
Vorstandsvorsitzender bei Bluejay Therapeutics, Inc.
Aktive Positionen von Keting Chu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Bluejay Therapeutics, Inc.
![]() Bluejay Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Bluejay Therapeutics, Inc. is a clinical stage private biopharmaceutical company that is committed to developing effective treatments and cures for viral and liver diseases. The company is based in San Mateo, CA, and was founded by Keting Chu, who has been the CEO since incorporation. The company's first target indication is chronic hepatitis b, which is a worldwide prevalent disease with an urgent unmet medical need. Bluejay is advancing two innovative approaches with the potential for a high rate of functional cure: fully human igg1 anti-hbs monoclonal antibodies and first-in-class hbsag oral small molecule inhibitors. The company believes that by reducing hepatitis b surface antigen and restoring adaptive immunity, a functional cure could be achieved for patients. | Vorstandsvorsitzender | - | - |
Vorsitzender | - | - | |
Gründer | - | - |
Karriereverlauf von Keting Chu
Ehemalige bekannte Positionen von Keting Chu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TempestTx, Inc.
![]() TempestTx, Inc. BiotechnologyHealth Technology TempestTx, Inc. is a clinical stage biotechnology company which engages in advancing small molecule therapeutics that modulate anti-tumor pathways. The company is headquartered in South San Francisco, CA. | Direktor/Vorstandsmitglied | - | - |
Statistik
International
Vereinigte Staaten | 3 |
Operativ
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Chairman | 1 |
Sektoral
Health Technology | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
TempestTx, Inc.
![]() TempestTx, Inc. BiotechnologyHealth Technology TempestTx, Inc. is a clinical stage biotechnology company which engages in advancing small molecule therapeutics that modulate anti-tumor pathways. The company is headquartered in South San Francisco, CA. | Health Technology |
Bluejay Therapeutics, Inc.
![]() Bluejay Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Bluejay Therapeutics, Inc. is a clinical stage private biopharmaceutical company that is committed to developing effective treatments and cures for viral and liver diseases. The company is based in San Mateo, CA, and was founded by Keting Chu, who has been the CEO since incorporation. The company's first target indication is chronic hepatitis b, which is a worldwide prevalent disease with an urgent unmet medical need. Bluejay is advancing two innovative approaches with the potential for a high rate of functional cure: fully human igg1 anti-hbs monoclonal antibodies and first-in-class hbsag oral small molecule inhibitors. The company believes that by reducing hepatitis b surface antigen and restoring adaptive immunity, a functional cure could be achieved for patients. | Commercial Services |
- Börse
- Insiders
- Keting Chu
- Erfahrung